MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy

P. Dowell, B. Patel, L. Ledbetter, K. Lyons, R. Pahwa (Kansas City, KS, USA)

Meeting: 2017 International Congress

Abstract Number: 180

Keywords: Magnetic resonance imaging(MRI), Parkinsonism, Progressive supranuclear palsy(PSP)

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To evaluate the sensitivity and specificity of a radiographic marker, midbrain to pons ratio, in brain MRI of Progressive Supranuclear Palsy (PSP) patients as evaluated by different medical specialists.

Background: PSP can be clinically challenging to diagnose early in the disease. Recent investigations show that radiographic markers may aid in the diagnoses; one marker of interest is the midbrain to pons ratio on brain MRI and its sensitivity and specificity in PSP. One study has demonstrated that in a clinically and pathologically confirmed PSP cohort a midbrain to pons ratio of less than 0.52 was 100% specific and 85.7% sensitive for PSP.1 This ratio is a simple marker that is calculated from midsagittal brain MRI. Application of this tool in clinic may be useful; however variability of measurements amongst different medical specialists may affect the usefulness of this marker.

Methods: A clinically confirmed cohort of age and gender matched PSP and Parkinson’s disease (PD) patients who had brain MRI with midsagittal images was selected from the University of Kansas Medical Center’s movement Disorder database. Measurements obtained included the midbrain and pons short axis diameter. The midbrain to pons ratio was calculated by dividing the midbrain to pons measurements. The measurements were obtained by a neuroradiologist and a senior neurology resident. Both raters were blinded to clinical information.

Results: Twelve PSP patients with a mean age of 69 years on date of MRI (range 64-77) and 12 PD patients with a mean age of 70 years on date of MRI (range 63-76) were evaluated. Each group was comprised of 83% males. When measured by the neuroradiologist, 12 of 12 PSP patients had a midbrain to pons ratio of less than 0.52, and 2 of 12 PD patients were also measured to be in the PSP range. This resulted in 100% sensitivity and 83% specificity. When measured by the senior neurology resident, 10 of 12 PSP patients had a midbrain to pons ratio of less than 0.52, and 2 of 12 PD patients were also measured to be in the PSP range. This resulted in a lower sensitivity than the neuroradiologist at 83% but the same specificity as the neuroradiologist at 83% for PSP.

Conclusions: The midbrain to pons ratio as a radiological marker may aid in the diagnosis of PSP. It appears that this is a sensitive and specific measure whether calculated by a neuroradiologist or a senior neurology resident.

References: The midbrain to pons ratio: A simple and specific MRI sign of progressive supranuclear palsy. Massey, L, et al. Neurology. May 14, 2013, 80:20 1856-1861.

Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy. Owens, E, et al. Parkinsonism and Related Disorders. May 2, 2016. 28.107-111.

To cite this abstract in AMA style:

P. Dowell, B. Patel, L. Ledbetter, K. Lyons, R. Pahwa. Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/evaluation-of-a-radiographic-marker-as-a-diagnostic-tool-for-progressive-supranuclear-palsy/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluation-of-a-radiographic-marker-as-a-diagnostic-tool-for-progressive-supranuclear-palsy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley